AI assistant
Sending…
ZEVRA THERAPEUTICS, INC. — Director's Dealing 2021
Nov 18, 2021
32811_dirs_2021-11-18_4f182ff2-7796-49ac-b278-cd807b5a7599.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: KEMPHARM, INC (KMPH)
CIK: 0001434647
Period of Report: 2021-11-18
Reporting Person: Clifton R. LaDuane (CFO, Secretary & Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-18 | Common Stock | P | 510 | $8.29 | Acquired | 5240 | Direct |
More from ZEVRA THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 6
Proxy Solicitation & Information Statement
2026
Apr 20
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2